Philip D. Harvey

1.4k total citations
9 papers, 1.1k citations indexed

About

Philip D. Harvey is a scholar working on Psychiatry and Mental health, Philosophy and Cognitive Neuroscience. According to data from OpenAlex, Philip D. Harvey has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Philosophy and 2 papers in Cognitive Neuroscience. Recurrent topics in Philip D. Harvey's work include Schizophrenia research and treatment (6 papers), Mental Health and Psychiatry (5 papers) and Mental Health Research Topics (1 paper). Philip D. Harvey is often cited by papers focused on Schizophrenia research and treatment (6 papers), Mental Health and Psychiatry (5 papers) and Mental Health Research Topics (1 paper). Philip D. Harvey collaborates with scholars based in United States, Israel and Canada. Philip D. Harvey's co-authors include James M. Gold, Danny Koren, Avi Reichenberg, Christopher R. Bowie, L. J. Seidman, Morris Goldsmith, David P. Bernstein, Emil F. Coccaro, Mark R. Serper and Michael Davidson and has published in prestigious journals such as Molecular Psychiatry, Schizophrenia Bulletin and Psychiatry Research.

In The Last Decade

Philip D. Harvey

8 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip D. Harvey United States	5	776	345	288	267	216	9	1.1k
Margaret M. McClure United States	17	850 1.1×	328 1.0×	333 1.2×	337 1.3×	195 0.9×	38	1.1k
Trina M. Walker United States	9	830 1.1×	320 0.9×	287 1.0×	155 0.6×	213 1.0×	13	986
Mariachiara Buonocore Italy	20	668 0.9×	373 1.1×	233 0.8×	240 0.9×	249 1.2×	61	1.0k
Philip D. Harvey United States	13	765 1.0×	367 1.1×	273 0.9×	243 0.9×	148 0.7×	16	966
Scott W Woods United States	11	536 0.7×	249 0.7×	241 0.8×	224 0.8×	214 1.0×	17	964
Michael Bodnar Canada	20	901 1.2×	586 1.7×	248 0.9×	175 0.7×	251 1.2×	43	1.2k
R. D. Stieglitz Switzerland	14	989 1.3×	632 1.8×	227 0.8×	454 1.7×	157 0.7×	49	1.4k
Ana M. Sánchez-Torres Spain	19	815 1.1×	310 0.9×	197 0.7×	210 0.8×	196 0.9×	69	1.0k
Daniela Roesch-Ely Germany	22	843 1.1×	644 1.9×	345 1.2×	221 0.8×	432 2.0×	48	1.5k
R. W. Buchanan United States	8	690 0.9×	187 0.5×	271 0.9×	170 0.6×	131 0.6×	8	853

Countries citing papers authored by Philip D. Harvey

Since Specialization

Citations

This map shows the geographic impact of Philip D. Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Harvey more than expected).

Fields of papers citing papers by Philip D. Harvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Harvey. The network helps show where Philip D. Harvey may publish in the future.

Co-authorship network of co-authors of Philip D. Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Harvey. A scholar is included among the top collaborators of Philip D. Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Harvey. Philip D. Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Harvey, Philip D., et al.. (2025). Cognitive impairment in schizophrenia: when, what, and is it remediable?. Current Opinion in Psychiatry. 38(3). 154–158. 1 indexed citations

Nucifora, Leslie G., Koko Ishizuka, Brian J. Lee, et al.. (2025). Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patients. Molecular Psychiatry. 30(8). 3673–3685. 2 indexed citations

Harvey, Philip D., et al.. (2025). An overview of the challenges with the differential diagnosis of schizotypal personality disorder. Expert Review of Neurotherapeutics. 25(6). 689–698.

Harvey, Philip D., et al.. (2024). Efficacy and safety of iclepertin (BI 425809) with adjunctive computerized cognitive training in patients with schizophrenia. Schizophrenia Research Cognition. 40. 100340–100340. 3 indexed citations

Koren, Danny, L. J. Seidman, Morris Goldsmith, & Philip D. Harvey. (2006). Real-World Cognitive--and Metacognitive--Dysfunction in Schizophrenia: A New Approach for Measuring (and Remediating) More "Right Stuff". Schizophrenia Bulletin. 32(2). 310–326. 182 indexed citations

Harvey, Philip D., Danny Koren, Avi Reichenberg, & Christopher R. Bowie. (2005). Negative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?. Schizophrenia Bulletin. 32(2). 250–258. 354 indexed citations

Gold, James M. & Philip D. Harvey. (1993). Cognitive Deficits in Schizophrenia. Psychiatric Clinics of North America. 16(2). 295–312. 305 indexed citations

Coccaro, Emil F., et al.. (1991). Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior.. PubMed. 3(2). S44–51. 151 indexed citations

Serper, Mark R., et al.. (1991). Continuous performance tests in schizophrenic patients: Stimulus and medication effects on performance. Psychiatry Research. 37(1). 47–56. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact